Overview

A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety, tolerability, pharmacokinetics and pharmacodynamics of SLV337 in patients with type 2 diabetes
Phase:
Phase 2
Details
Lead Sponsor:
Abbott Products
Collaborator:
Quintiles, Inc.